The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it ...
Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the ...
Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry ...
The U.S. Federal Trade Commission filed an enforcement action against payment platform Doxo, Steve Shivers and Roger Parks on April 25 in Washington Western District Court. The complaint accuses ...
The Federal Trade Commission is seemingly seeking to clear the path for generic versions of the weight loss drug Ozempic — but there will be a long road ahead before cheaper versions of the ...
Subaru was slapped with a patent infringement lawsuit on May 14 in Texas Eastern District Court. The lawsuit was brought by Garteiser Honea PLLC on behalf of Infogation Corp., which targets Subaru ...
Non-Compete Agreements are contracts, typically formed in employment or business purchase contexts, where one party agrees to refrain from engaging in a particular line of work or pursuing ...
Drug patents are used, and sometimes abused, as a way to protect pharma profits by limiting competition. From gamesmanship with patent thickets to questionable practices with the FDA Orange Book ...